UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library. Online Urology & Urologic Oncology Journal Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display 5 10 15 20 25 30 50 results per page Results 1 - 50 of 2427 << Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >> Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: Possible therapeutic implications - Abstract Friday, 03 September 2010 Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Login to read more... Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: A technology of the future? - Abstract Friday, 03 September 2010 Department of Urology, Universitätsmedizin, Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany. Login to read more... Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy - Abstract Thursday, 02 September 2010 Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Login to read more... The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer - Abstract Thursday, 02 September 2010 Caritas St Josef Medical Center, Department of Urology, University of Regensburg, Landshuterstrasse 65, 93053 Regensburg, Germany. Login to read more... Increasing selenium intake may decrease bladder cancer risk Wednesday, 01 September 2010 PHILADELPHIA, PA USA (News Release) - August 31, 2010 Login to read more... Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: Analysis of 221 cases - Abstract Wednesday, 01 September 2010 Section of Oncology-Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA. Login to read more... Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer - Abstract Wednesday, 01 September 2010 Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Login to read more... Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center - Abstract Wednesday, 01 September 2010 Department of Urology and Pediatric Urology, Medical Clinic III, Johann Wolfgang Goethe-University, Frankfurt, Germany. Login to read more... Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer - Abstract Wednesday, 01 September 2010 Centre Hospitalier de l'Université de Montréal, Quebec, Canada. Login to read more... Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline - Abstract Tuesday, 31 August 2010 School of Medicine, Queen's University, Kingston, ON. Login to read more... Clinical outcomes of patients with pT0 bladder cancer after radical cystectomy: A single-institute experience - Abstract Tuesday, 31 August 2010 Department of Urology, School of Medicine, Sapporo Medical University, Sapporo, Hokkaido, Japan. Login to read more... Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: Management and results at long-term follow-up - Abstract Monday, 30 August 2010 Department of Urology, Fundació Puigvert, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Login to read more... MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy - Abstract Monday, 30 August 2010 Department of Medicine (Cancer Research), West German Cancer Center, University Duisburg-Essen, Essen, Germany. Login to read more... Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy - Abstract Friday, 27 August 2010 Department of Urology, University of Bologna, S Orsola-Malpighi General Hospital, Pelagio Palagi 9 Street, 40138 Bologna, Italy. Login to read more... Translational research in bladder cancer: From molecular pathogenesis to useful tissue biomarkers - Abstract Friday, 27 August 2010 Departments of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Login to read more... Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study - Abstract Thursday, 26 August 2010 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland. Login to read more... Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: Short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99] - Abstract Thursday, 26 August 2010 Department of Urology, Düsseldorf University, Düsseldorf. Login to read more... Maratona Urológica 2010 - Muscle invasive bladder cancer: Case discussion panel - Session Highlights Wednesday, 25 August 2010 RIO DE JANEIRO, BRAZIL (UroToday.com) - Going to the fat on transurethral resection of bladder tumor (TURBT) is not a standard procedure and precludes the use of mitomycin C on postoperative period. Login to read more... The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer - Abstract Wednesday, 25 August 2010 Institute of Oncology, Vilnius University, Santariskiu 1, 08660 Vilnius, Lithuania. Login to read more... Evaluation and management of hematuria - Abstract Wednesday, 25 August 2010 Department of Family Medicine, University of Michigan, 1018 Fuller Street, Ann Arbor, MI 48104, USA. Login to read more... Management of the male urethra after cystectomy - Abstract Tuesday, 24 August 2010 Division of Urology, Department of Surgery, University of Pennsylvania School of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA. Login to read more... Significance of age and comorbidity as prognostic indicators for patients with bladder cancer - Abstract Tuesday, 24 August 2010 Department of Urology, College of Medicine, Chung-Ang University, Seoul 140-757, Korea. Login to read more... Inaugural Bladder Cancer Research Award presented by Bladder Cancer Advocacy Network Monday, 23 August 2010 BETHESDA, MD USA (Press Release) - August 23, 2010 Login to read more... Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center - Abstract Monday, 23 August 2010 Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. Login to read more... Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients - Abstract Monday, 23 August 2010 Department of Pathology, CHU Farhat-Hached, 4000 Sousse, Tunisia. Login to read more... Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-World Health Organization/InternationalSociety of Urological Pathology classification cohort from a single academic center - Abstract Monday, 23 August 2010 Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. Login to read more... Analysis of clinical, histopathological and follow-up data on transurethral resections of the bladder performed during one year at a university centre - Abstract Friday, 20 August 2010 Caritas-Krankenhaus St. Josef, Klinik und Poliklinik für Urologie der Universität Regensburg. Login to read more... A water soluble parthenolide analogue suppresses in vivo tumor growth of two tobacco associated cancers, lung and bladder cancer, by targeting NF-kappaB and generating reactive oxygen species - Abstract Friday, 20 August 2010 Department of Medicine, Indiana University, Indianapolis, IN, USA. Login to read more... Delays in diagnosis and bladder cancer mortality - Abstract Thursday, 19 August 2010 Department of Urology, Division of Oncology, University of Michigan Health System, Ann Arbor, Michigan. Login to read more... Radical cystectomy for bladder cancer in the 70+ population: A nation-wide registry analysis of 845 patients - Abstract Thursday, 19 August 2010 Department of Urology and Andrology, Danube Hospital, Vienna, Austria. Login to read more... Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma - Abstract Wednesday, 18 August 2010 Moorfields Eye Hospital, London, UK. Login to read more... A potent chemotherapeutic strategy for bladder cancer: (S)-methoxy-trityl-L-cystein, a novel Eg5 inhibitor - Abstract Wednesday, 18 August 2010 Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Login to read more... Extended lymphadenectomy in bladder cancer - Abstract Tuesday, 17 August 2010 USC Institute of Urology, Keck School of Medicine, Los Angles, California, USA. Login to read more... Expanding therapeutic targets in bladder cancer: The PI3K/Akt/mTOR pathway - Abstract Tuesday, 17 August 2010 Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. Login to read more... Beyond the Abstract - Systemic therapy of metastatic bladder cancer in the molecular era: Current status and future promise, by Athanasios G. Papavassiliou, MD, PhD, et al. Monday, 16 August 2010 BERKELEY, CA (UroToday.com) - This article presents the current status of conventional chemotherapy in advanced bladder cancer, and provides a comprehensive review of molecular targeted agents that are currently in clinical development for this disease. Login to read more... Radiotherapy in localized bladder cancer: What is the evidence? - Abstract Monday, 16 August 2010 aHarrogate District Hospital, Harrogate, Yorkshire, UK bRoyal Cornwall Hospital, Truro, Cornwall, UK. Login to read more... Cancer stem cells in bladder cancer: A revisited and evolving concept - Abstract Monday, 16 August 2010 aUrology, Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA bUrology, USA cInstitute for Stem Cell Biology & Regenerative Medicine, Stanford University, Palo Alto, California, USA. Login to read more... Will tissue-engineered urinary bladders change indications for a laparoscopic cystectomy? - Abstract Friday, 13 August 2010 Nicolaus Copernicus Universityand Institute of Oncology, Bydgoszcz, Poland. Login to read more... Follow-up of patients after curative bladder cancer treatment: Guidelines vs. practice - Abstract Friday, 13 August 2010 Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Login to read more... Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers? - Abstract Friday, 13 August 2010 Department of Urology, Eberhard-Karls University, Tuebingen, Germany. Login to read more... Predictive value of fluorescence in situ hybridization in patients with bladder cancer - Abstract Thursday, 12 August 2010 Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Login to read more... The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder - Abstract Thursday, 12 August 2010 Department of Urologic Oncology, MD Anderson Cancer Center. Login to read more... The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients - Abstract Thursday, 12 August 2010 Department of Surgery, Division of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, Michigan 48202, USA. Login to read more... Review of transurethral endoscopic surgery - Abstract Wednesday, 11 August 2010 Department of Urology, Tokai University Hachioji Hospital. Login to read more... Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells - Abstract Wednesday, 11 August 2010 Klinik für Urologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Germany. Login to read more... Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: Basic skills - Abstract Wednesday, 11 August 2010 Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Login to read more... Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer - Abstract Tuesday, 10 August 2010 Department of Urology, Erasmus MC, Rotterdam, The Netherlands. Login to read more... Bladder cancer risk in painters: A meta-analysis - Abstract Tuesday, 10 August 2010 Section of IARC Monographs, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. Login to read more... Bladder cancer in patients after organ transplantation - Abstract Monday, 09 August 2010 Department of Urology, Centre Hospitalo-Universitaire Pellegrin-Tripode, France. Login to read more... Stage pT0 at radical cystectomy confers improved survival: An international study of 4,430 patients - Abstract Monday, 09 August 2010 Department of Urology, Ludwig-Maximilians-University Munich, Klinikum Grosshadern, Munich, Germany. Login to read more... Focus on Bladder Cancer Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff. Exclusive! Interview with Barry Stein, MD on Clinical Practice Experience with NMP22 Podcast - San Francisco Firefighters and Bladder Cancer Screening The forgotten cancer: Bladder cancer and women - A Presentation by Liam J. Hurley, MD, FACS   Veterans' health: Improved detection and surveillance of bladder cancer - A Presentation by Liam J. Hurley, MD, FACS Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: Review of the evidence and recommendations - by J. Alfred Witjes, MD Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin - by Ofer Nativ, MD - Video Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: A case report and review of the literature - by Miguel Alvarez-Mugica, MD Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells - by Sensuke Konno, PhD, et al. Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? - by Clive Shiff, MD and Robert W. Veltri, MD External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients - by lze E.W. van Onna, MD Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand? - by Samir Shirodkar, MD Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer - by Paolo Emiliozzi, MD Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? - by Christopher P. Evans, MD, FACS The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience - by David P. Wood, Jr. MD Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy - by David P. Wood, Jr. MD Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer - by David P. Wood, Jr. MD Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men - by David P. Wood, Jr. MD Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma - by David P. Wood, Jr. MD Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness - by Ricardo Sånchez-Ortiz, MD - Editor's Pick Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years - by David P. Wood, Jr. MD - Editor's Pick A Rare Case of Adenocarcinoma of the Urinary Bladder - by Saleem M. Wani, MD, et al. Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer - by Yassine Nouira, MD, et al. Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer - by Siavash Falahatkar, MD, et al. A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria - by Louis S. Liou, MD, et al. Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence - by Ravi Munver, MD, et al. Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy - by Mitchell C. Benson, MD, and James M McKiernan, MD Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer - by Peter J. Goebell, MD, et al. Biomarkers in bladder cancer The effect of age and gender on bladder cancer: A critical review of the literature Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection? Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies Bladder Cancer Screening Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay - by Mark S. Soloway, MD Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test - CME Training Program Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay - Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? - Yair Lotan, MD on Screening for Bladder Cancer Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer - Giora Katz, MD Reports on Increased Risk for Bladder Cancer Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study - Giora Katz, MD on the Utility of NMP22 Bladdercheck Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay - H. Barton Grossman, MD & the NMP22 Clinical Investigation Group 2010 Genitourinary Cancers Symposium - View Bladder Cancer Session Highlights from 2010 Genitourinary Cancers Symposium 10th Annual Winter Meeting of the Society of Urologic Oncology - View Bladder Cancer Session Highlights from the 2009 SUO Winter Meeting The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder - Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines - Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting Improving survival for patients with bladder cancer - Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting Fluorescence cystoscopy for detection of initial and recurrent bladder cancer - Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting Early cystectomy for T1 bladder cancer - Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica Treatment of muscle invasive bladder cancer in elderly - Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield - Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost - Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder - Presented by Stephen A. Boorjian, MD American Society of Clinical Oncology (ASCO) 2009 Annual Meeting - View Bladder Cancer Session Highlights American Urological Association (AUA) 2009 Annual Meeting - View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting 10 Tips for Non-Muscle Invasive Bladder Cancer - Lecture presented at WUF 2009 by David P. Wood, Jr., MD Society of Urologic Oncology (SUO) 9th Annual Winter Meeting - View Bladder Cancer Session Highlights Robot Assisted Radical Cystectomy: Is it Ready for Prime Time? - Session Highlight from AUA Western Section 2008 Bladder Cancer Cytology and Markers in Diagnosis and Assessment - Presentation from the 2008 AUA NY Meeting Re-Staging Transurethral Resection: Who Benefits? - Slide Presentation from the 2008 AUA NY Section Meeting Non-Muscle Invasive Transitional Cell Carcinoma - Slide Presentation from the 2008 Masters in Urology Conference American Society of Clinical Oncology 44th Annual Meeting - Bladder Cancer Abstracts The American Urological Association 2008 Annual Meeting - Bladder Cancer Session Highlights Engineering and Urology Society 23rd Annual Meeting - Bladder Cancer Abstracts   << Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >> Results 1 - 50 of 2427

Content on UroToday and UroToday International Journal is copyrighted and can be used for personal, noncommercial use only. You can order presentation-ready copies for distribution to your colleagues, clients or customers by emailing UroToday at commercialreprints@urotoday.com. Request a reprint quote of this article now, please include the title of the article and number or copies requested.

UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use Privacy Policy | © 2010 Digital Science Press, Inc ® All Rights Reserved